Company recently reversed split leaving low float. Fintel shows decent shorted percentage of float, high cost to borrow and no shares available to borrow, however the days to cover is low. Maybe a catalyst or pressure can push it over …
# Biggest potential losers |Ticker|Stock price (USD)|Premarket change|Why it's moving| |:-|:-|:-|:-| |NCPL|$1.04|−20.31%|Group chat pushing it down . catalyst needs confirmation.| |AIXI|$1.70|−13.04%|Heavy selling pressure; no verified company-specific explanation in the available snapshot.| |LGCL|$2.15|−12.24%|Sharp decline on relatively low reported premarket volume.| |INTJ|$2.95|−11.14%|Significant …
# Biggest potential winners |Ticker|Stock price (USD)|Premarket change|Why it's moving| |:-|:-|:-|:-| |MI|$1.18|\+33.62%|Major premarket momentum; a specific news catalyst still needs confirmation.| |NTCL|$2.20|\+21.55%|Strong percentage move, but the underlying company announcement needs verification.| |XRTX|$2.08|\+14.29%|Sharp move in a low-priced stock; check for company-specific …
I randomly stepped in this stock and I was wondering if it has any chance to make me earn a good amount from it. BLISS technology seems sick. Let me know if you own this stock or have any insight.
Hyliion, ticker HYLN, is no longer really the EV truck company many investors remember from the SPAC boom. Today, almost the entire story revolves around KARNO, the modular generator technology Hyliion acquired from GE. And the opportunity sounds big. but …
I have been following Standard Dental Labs for some time and while highly volatile I want to point to 2 recent press releases that I think have been completely overlooked. For reference, the market capitalization sits at \~$2.5m today. First, …
Anyone else following SLS heading into the end of the year? My interest comes down to three things: patients still receiving GPS years into treatment, an approaching Phase 3 survival analysis, and a second AML drug with encouraging clinical data. …
My first time at this subreddit, please be kind, i am new in otc (i think this is not a otc, but here i am to learn more about it) What do you think about aston martin stock going very …
Are there other investors in CMPS here? Comp360 is proprietary psilocybin, that’s being studied in treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). Comp360 looks to be the first psychedelic to market. Their phase 3 studies (comp005 and comp006) in …
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.